| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4058 | Pdi-in-p1 | Protein disulfide isomerase (PDI) inhibitor |
|
| DCC4059 | Pd-l1 Degrader F4 | Novel PD-L1 degrader, showing 66.99% degradation activity at 20 μM with no calcium blocking effect, strengthening the T cell-mediated killing of tumor cells |
|
| DCC4060 | Pd-l1 Degrader P22 | Novel PROTAC dual inhibitor and degrader of PD-L1, inhibiting PD-1/PD-L1 interaction with IC50 of 39.2 nM in an HTRF binding assay |
|
| DCC4061 | Pd-l1 Inhibitor L7 | Novel Potent PD-L1 Inhibitor (IC50 1.8 nM), binding to human PD-L1 (hPD-L1) with a KD value of 3.34 nM, without showing any binding to hPD-1, blocking PD-1/PD-L1 interaction with an EC50 value of 375 nM |
|
| DCC4062 | Pdsinh-c01 | Novel pendrin inhibitor, inhibiting Cl-/anion exchange mediated by mouse pendrin without affecting other major kidney tubule transporters |
|
| DCC4063 | Peg-vtx | Novel polyethylene glycol (PEG)-drug conjugate of Venetoclax, a Bcl-2 inhibitor, for treatment of acute myeloid leukemia (AML) |
|
| DCC4064 | Pelorol | Activator of SHIP-1 |
|
| DCC4065 | pemedolac | Cyclooxygenase Inhibitor and Prostagladin Synthase Inhibitor |
|
| DCC4066 | Penb-l-glutamate | Novel caged glutamate |
|
| DCC4067 | Penclomedine | Antineoplastic agent, alkylating and crosslinking DNA, resulting in DNA strand breaks and inhibition of DNA and RNA synthesis |
|
| DCC4068 | Penicillic Acid | Mycotoxin with antibiotic and carcinogenic activity |
|
| DCC4069 | penicillin K | Antibiotic, a natural penicillin, synthesized in vitro by incubating (S-octanoyl)glutathione, 6-APA and AT |
|
| DCC4070 | Penindolone | Novel potent and broad-spectrum anti-influenza A virus (anti-IAV) activities with low risk of inducing drug resistance |
|
| DCC4071 | Pentamidine Dimesylate | Inhibitor of calcium-dependent complex formation with p53 [(Ca)S100B-p53] in malignant melanoma (MM), restoring p53 tumor suppressor activity in vivo |
|
| DCC4072 | Peptide 1018 | Innate defense regulator, target stringent response-controlled virulence in a Pseudomonas aeruginosa murine cutaneous infection model |
|
| DCC4073 | Peptide 4f | ApoA-I/HDL mimetic peptide, efficiently crossing the blood-brain barrier and modulating amyloid beta distribution between brain and plasma |
|
| DCC4074 | Peptide P9r | Broad-spectrum virus- and host-targeting peptide, inhibiting coronaviruses and other respiratory viruses |
|
| DCC4075 | Pergolide Mesylate | Agonist of dopamine receptor subtypes D1 and D2 |
|
| DCC4076 | Peridinin | Exceptionally Potent and Membrane-Embedded Inhibitor of Bilayer Lipid Peroxidation |
|
| DCC4077 | Perindopril | Non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor |
|
| DCC4078 | Pet-16 | Novel allosteric inhibitor of E. coli Hsp70 (DnaK) and human Hsp70 proteins |
|
| DCC4079 | Pex14-pex5 Inhibitor-5 | First Inhibitor of PEX14-PEX5 Protein-Protein Interaction (PPI) with Trypanocidal Activity |
|
| DCC4080 | Pf-03084014 | Novel γ-secretase inhibitor |
|
| DCC4081 | Pf-03671148 | Dose dependent inhibitor of multiple fibrotic genes |
|
| DCC4082 | Pf-04363467 Hydrochloride | Selective dopamine D3/D2 receptor antagonist |
|
| DCC4083 | Pf-04671536 Hydrochloride | Novel potent and selective PDE8B/8A inhibitor |
|
| DCC4084 | pf-04859989 | Irriversible inhibitor of kynurenine amino transferase II (KAT II) |
|
| DCC4085 | Pf-05109794 | Novel selective hTRPV4 Antagonist (hTRPV4 IC50 49nM; rTRPV4 IC50 1,150nM) |
|
| DCC4086 | Pf-05214030 | Novel potent TRPV4 antagonist (hTRPV4 IC50 4nM; rTRPV4 IC50 27nM) |
|
| DCC4087 | Pf-06371900 | Novel potent and highly selective leucine rich repeat kinase 2 (LRRK2) inhibitor |
|
